相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bisubstrate Ether-Linked Uridine-Peptide Conjugates asO-GlcNAc Transferase Inhibitors
Vivek Makwana et al.
CHEMMEDCHEM (2021)
Investigating the Impact of OGT Inhibition on Doxorubicin- and Docetaxel-Induced Cytotoxicity in PC-3 and WPMY-1 Cells
Vivek Makwana et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2020)
Angiogenesis Inhibition in Prostate Cancer: An Update
Chandrani Sarkar et al.
CANCERS (2020)
Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation
Yubo Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Essential role of O-GlcNAcylation in stabilization of oncogenic factors
Vivek Makwana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2019)
Role of Androgen Receptor in Prostate Cancer: A Review
Kazutoshi Fujita et al.
WORLD JOURNAL OF MENS HEALTH (2019)
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
Harri M. Itkonen et al.
THERANOSTICS (2019)
Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)
Mitchell E. Gross et al.
CLINICAL GENITOURINARY CANCER (2018)
O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance
Yubo Liu et al.
CELL DEATH & DISEASE (2018)
Emerging Therapies in Metastatic Prostate Cancer
Daniel W. Sonnenburg et al.
CURRENT ONCOLOGY REPORTS (2018)
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Ferdinando Chiaradonna et al.
CELLS (2018)
Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling
Gentry K. Cork et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Cross-Dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases
Ninon Very et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer
Jingwen Zhang et al.
APOPTOSIS (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
Karim Fizazi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer
Y. Li et al.
ONCOGENE (2017)
AR Signaling and the PI3K Pathway in Prostate Cancer
Megan Crumbaker et al.
CANCERS (2017)
The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
Kurtis Eisermann et al.
CANCERS (2017)
Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer
Giuseppe Galletti et al.
CANCER TREATMENT REVIEWS (2017)
Opportunities and challenges provided by crosstalk between signalling pathways in cancer
A. Prahallad et al.
ONCOGENE (2016)
O-GIcNAcylation in Cancer Biology: Linking Metabolism and Signaling
Christina M. Ferrer et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas D. James et al.
LANCET (2016)
The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5 (Publication with Expression of Concern. See vol. 10, 2017)
Logan Fulford et al.
SCIENCE SIGNALING (2016)
Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review
Archana Anantharaman et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Harri M. Itkonen et al.
ONCOTARGET (2016)
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
Heba Alshaker et al.
ONCOTARGET (2016)
The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5 (Publication with Expression of Concern. See vol. 10, 2017)
Logan Fulford et al.
SCIENCE SIGNALING (2016)
A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer
Kevin D. Courtney et al.
CLINICAL GENITOURINARY CANCER (2015)
Hypoxia and Prostate Cancer Aggressiveness: A Tale With Many Endings
Avelino Fraga et al.
CLINICAL GENITOURINARY CANCER (2015)
Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance
Lei Chang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer
Valerie L. Sodi et al.
MOLECULAR CANCER RESEARCH (2015)
Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
Fei Gao et al.
ONCOTARGET (2015)
Androgen receptor: structure, role in prostate cancer and drug discovery
M. H. Eileen Tan et al.
ACTA PHARMACOLOGICA SINICA (2015)
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk
Jason E. Michaud et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells
Yuchao Gu et al.
MOLECULAR MEDICINE REPORTS (2014)
Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients
T. Kamigaito et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2014)
Hexokinase 2-Mediated Warburg Effect Is Required for PTEN- and p53-Deficiency-Driven Prostate Cancer Growth
Lei Wang et al.
CELL REPORTS (2014)
O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells
Harri M. Itkonen et al.
CANCER RESEARCH (2013)
Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2
K. M. Biernacka et al.
ENDOCRINE-RELATED CANCER (2013)
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
Himisha Beltran et al.
EUROPEAN UROLOGY (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
O-GlcNAcylation-Inducing Treatments Inhibit Estrogen Receptor α Expression and Confer Resistance to 4-OH-Tamoxifen in Human Breast Cancer-Derived MCF-7 Cells
Shahzina Kanwal et al.
PLOS ONE (2013)
Landmarks in hormonal therapy for prostate cancer
Peter Hammerer et al.
BJU INTERNATIONAL (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
The androgen/androgen receptor axis in prostate cancer
Eric G. Bluemn et al.
CURRENT OPINION IN ONCOLOGY (2012)
The Androgen Receptor Gene Mutations Database: 2012 Update
Bruce Gottlieb et al.
HUMAN MUTATION (2012)
Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis
Thomas P. Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
Gerald W. Hart et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80 (2011)
Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
David J. Mulholland et al.
CANCER CELL (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
Charles E. Massie et al.
EMBO JOURNAL (2011)
Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells
Tracey M. Gloster et al.
NATURE CHEMICAL BIOLOGY (2011)
Androgen receptor signaling and mutations in prostate cancer
Shahriar Koochekpour
ASIAN JOURNAL OF ANDROLOGY (2010)
Prostate Cancer
James Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Arachidonic Acid Activation of Intratumoral Steroid Synthesis During Prostate Cancer Progression to Castration Resistance
Jennifer A. Locke et al.
PROSTATE (2010)
O-GIcNAc signaling: a metabolic link between diabetes and cancer?
C. Slawson et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Treatment of prostate cancer with hormonal therapy in Europe
Kurt Miller et al.
BJU INTERNATIONAL (2009)
MYC Activity Mitigates Response to Rapamycin in Prostate Cancer through Eukaryotic Initiation Factor 4E-Binding Protein 1-Mediated Inhibition of Autophagy
Bala S. Balakumaran et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
An Emerging Role of mTOR in Lipid Biosynthesis
Mathieu Laplante et al.
CURRENT BIOLOGY (2009)
Magnolol Induces Apoptosis Via Inhibiting the EGFR/PI3K/Akt Signaling Pathway in Human Prostate Cancer Cells
Dae-Hee Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Expression of Multidrug Resistance Proteins in Prostate Cancer Is Related With Cell Sensitivity to Chemotherapeutic Drugs
Catherine Sanchez et al.
PROSTATE (2009)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
Adam Schayowitz et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Predictive value of PTEN and AR coexpression of sustained responsiveness to hormonal therapy in prostate cancer - A pilot study
Soha S. El Sheikh et al.
NEOPLASIA (2008)
PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis
Jing Fang et al.
CELLULAR SIGNALLING (2007)
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion
Sanjeev Shulkla et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer
Rile Li et al.
HUMAN PATHOLOGY (2007)
Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development
Jing Jiao et al.
CANCER RESEARCH (2007)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Renee Chmelar et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer
Irina U. Agoulnik et al.
CANCER RESEARCH (2006)
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
Shaoyong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability
Won Ho Yang et al.
NATURE CELL BIOLOGY (2006)
Emergence of androgen independence at early stages of prostate cancer progression in Nkx3.1;: Pten mice
Hui Gao et al.
CANCER RESEARCH (2006)
Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins
Youyuan Xu et al.
CANCER RESEARCH (2006)
Current development of mTOR inhibitors as anticancer agents
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
MK Holz et al.
CELL (2005)
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression
IU Agoulnik et al.
CANCER RESEARCH (2005)
The emerging role of the PI3-K-Akt pathway in prostate cancer progression
L Li et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder et al.
NATURE MEDICINE (2004)
The androgen receptor gene mutations database (ARDB): 2004 update
B Gottlieb et al.
HUMAN MUTATION (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer
N Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
K Inoki et al.
NATURE CELL BIOLOGY (2002)
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer
VJ Gnanapragasam et al.
BRITISH JOURNAL OF CANCER (2001)
FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse
KE Hentges et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Amplification of hypoxia-inducible factor 1α gene in prostate cancer
OR Saramäki et al.
CANCER GENETICS AND CYTOGENETICS (2001)
分享论文
